Oric Pharmaceuticals, Inc. Common Stock (ORIC) is a publicly traded Healthcare sector company. As of July 14, 2026, ORIC trades at $10.70 with a market cap of $1.08B and a P/E ratio of -7.10. ORIC moved +0.86% today. Year to date, ORIC is +28.97%; over the trailing twelve months it is -2.76%. Its 52-week range spans $3.90 to $14.93. Analyst consensus is strong buy with an average price target of $19.67. Rallies surfaces ORIC's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
10 analysts cover ORIC: 0 strong buy, 10 buy, 0 hold, 0 sell, and 0 strong sell. The consensus rating is strong buy. The average price target is $19.67.
| Metric | Value |
|---|---|
| Price | $10.70 |
| Market Cap | $1.08B |
| P/E Ratio | -7.10 |
| EPS | $-1.47 |
| Dividend Yield | 0.00% |
| 52-Week High | $14.93 |
| 52-Week Low | $3.90 |
| Volume | 682.94K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-129.47M |
| Gross Margin | 0.00% |
10 analysts cover ORIC: 0 strong buy, 10 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $19.67.